Cytr stock history

View the latest CytRx Corp. (CYTR) stock price, news, historical charts, analyst ratings and financial information from WSJ. CytRx - CYTR - Stock Price & News | The Motley Fool

Get breaking news and analysis on CytRx Corporation (CYTR) stock, price quote and chart, trading and investing tools. Financials Financials Financials Overview SEC Filings Historical Prices CYTR | CytRx Corp. Profile | MarketWatch Nov 06, 2019 · CytRx Corp. company facts, information and stock details by MarketWatch. View cytr business summary and other industry information. CYTRX CORP (CYTR) Interactive Stock Chart - Yahoo Finance CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today announced that effective CYTRX CORP (CYTR) Latest Stock News & Headlines - Yahoo ...

6 Feb 2020 Twitter and IBD 50 stock Leidos Holdings rallied, Microsoft topped the solid stock market outperformance, according to MarketSmith chart 

Historical Prices for CytRx Corporation (CYTR). CytRx Corporation (CYTR) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on CytRx Corporation (CYTR) stock, price quote and chart, trading and investing tools. Financials Financials Financials Overview SEC Filings Historical Prices CYTR | CytRx Corp. Profile | MarketWatch

23 Mar 2020 Real-time trade and investing ideas on CytRx Corporation CYTR from the largest community of traders and investors.

CytRx Corporation (CYTR) News – Find the latest company news headlines for CytRx Corporation and all the companies you research at NASDAQ.com CYTR Stock Quote - CytRx Corp. Stock Price Today CYTR stock quote, chart and news. Get CytRx Corp.'s stock price today. CytRx Corp. (CYTR) Stock Message Board - InvestorsHub Apr 01, 2020 · More Big News expected within 6 months like the Phase 2 readout of the Gaucher Disease trial and the Phase 3 interim results of sIBM trial (more infos below) .This low float stock has everything to be the next 10+ Bagger at current price the stock is more than a PURE GIFT . STRONG BUY and GL CytRx (CYTR) Market-Cap: $9,8 M CytRx - Wikipedia CytRx Corp. (NASDAQ: CYTR) is a biopharmaceutical research and development oncology company based in Los Angeles, California. The CytRx oncology pipeline includes clinical trials involving their lead drug aldoxorubicin. Aldoxorubicin (formerly INNO-206) is a modified form of doxorubicin, the popular anthracycline chemotherapeutic agent known as "red death".

Jun 28, 2019 · Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, …

CYTR:OTC US Stock Quote - CytRx Corp - Bloomberg Markets Stock analysis for CytRx Corp (CYTR:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

CYTR Payout Ratio % Dividend History information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending

CytRx - 30 Year Stock Price History | CYTR | MacroTrends Historical daily share price chart and data for CytRx since 1989 adjusted for splits. The latest closing stock price for CytRx as of June 03, 2019 is 0.31. The all-time high CytRx stock closing price was 1868.91 on January 15, 1992. The CytRx 52-week high stock price is … CytRx Corporation (CYTR) Insider Trading Activity (SEC ... Insider Trading information for CYTR is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt of filing insider holdings with the SEC. CytRx Corporation (CYTR) Market Stream - NASDAQ.com Stock Details Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain CHARTS Basic Chart Interactive Chart COMPANY NEWS Company Headlines Press Releases Market Stream STOCK ANALYSIS Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison FUNDAMENTALS

Get breaking news and analysis on CytRx Corporation (CYTR) stock, price quote and chart, trading and investing tools. Financials Financials Financials Overview SEC Filings Historical Prices CYTR | CytRx Corp. Profile | MarketWatch Nov 06, 2019 · CytRx Corp. company facts, information and stock details by MarketWatch. View cytr business summary and other industry information. CYTRX CORP (CYTR) Interactive Stock Chart - Yahoo Finance CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today announced that effective CYTRX CORP (CYTR) Latest Stock News & Headlines - Yahoo ... Get the latest CYTRX CORP (CYTR) stock news and headlines to help you in your trading and investing decisions.